← Back to Search

ARCR augmented with REGENETEN™ Bioinductive Implant for Rotator Cuff Injury (REGENETEN Trial)

N/A
Waitlist Available
Led By Chris Peach, MBBS MD FRCS (Tr&Orth)
Research Sponsored by Smith & Nephew, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 2 weeks, 6 weeks, 3, 6, 12 and 24 months

Summary

This trial is testing a shoulder tendon repair surgery with an extra treatment called REGENETEN. It targets patients with large or massive shoulder tears. REGENETEN helps by providing a structure for new tissue to grow, aiding the healing process. REGENETEN is a bioinductive type-1 collagen implant used to repair partial-thickness rotator cuff tears without formal tendon-bone reattachment.

Eligible Conditions
  • Rotator Cuff Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 2 weeks, 6 weeks, 3, 6, 12 and 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks, 6 weeks, 3, 6, 12 and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
6 months retear rate
Secondary study objectives
Constant-Murley Score
Cumulative duration of opioid use in ARCR augmented with REGENETEN versus ARCR alone
EuroQol 5 Dimension 5 Level (EQ-5D-5L) Score
+14 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: ARCR revision groupExperimental Treatment1 Intervention
ARCR revision group allows treatment of subjects having recurrent tears, ARCR supplemented with REGENETEN
Group II: ARCR augmented with REGENETEN™ Bioinductive ImplantExperimental Treatment1 Intervention
During the ARCR procedure, the REGENETEN™ Bioinductive Implant is covering the tendon and attached to the bone and the tendon with small anchors.
Group III: ARCR alonePlacebo Group1 Intervention
The rotator cuff is repaired during arthroscopic standard procedure. No product is added for healing

Find a Location

Who is running the clinical trial?

Smith & Nephew, Inc.Lead Sponsor
167 Previous Clinical Trials
21,962 Total Patients Enrolled
Chris Peach, MBBS MD FRCS (Tr&Orth)Principal InvestigatorManchester University NHS Foundation Trust
~24 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top